T2 Biosystems Extends Multi-Year Capital Equipment Supplier Agreement With Vizient; Vizient Members Continue Access To Broader Exposure And Contracted Pricing For T2Dx Instrument, T2Bacteria Panel And T2Candida Panel
Portfolio Pulse from Benzinga Newsdesk
T2 Biosystems has extended its multi-year capital equipment supplier agreement with Vizient. This extension allows Vizient members continued access to broader exposure and contracted pricing for T2Dx Instrument, T2Bacteria Panel, and T2Candida Panel.
March 28, 2024 | 1:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
T2 Biosystems extends its supplier agreement with Vizient, ensuring continued access to T2Dx Instrument, T2Bacteria Panel, and T2Candida Panel for Vizient members.
The extension of the supplier agreement with Vizient is likely to have a positive impact on T2 Biosystems' stock (TTOO) in the short term. This agreement ensures continued sales and exposure of their T2Dx Instrument, T2Bacteria Panel, and T2Candida Panel to Vizient members, which could lead to increased revenue and market confidence in T2 Biosystems' products and financial stability.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90